CRISPR/Cas13a-based Supersensitive Circulating Tumor DNA Assay for Detecting EGFR Mutations in Plasma
Yan He1,2, Dixian Luo2,3* and Zifen Gou1*
1Institute of Pharmacy and Pharmacology, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
2Department of Laboratory Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital (Nanshan Hospital), Shenzhen 518052, PR China
3Shenzhen University Medical School, Shenzhen 518060, PR China
He Y, Luo D, Gou Z. CRISPR/Cas13a-based Supersensitive Circulating Tumor DNA Assay for Detecting EGFR Mutations in Plasma. Asian Journal of Complementary and Alternative Medicine, Vol 12(2), 52-54:2024.